ESC 365 - Combined administration of atorvastatin and mesenchymal stem cells synergizes to attenuate inflammation and promote efferocytosis in atherosclerotic mice

ESC Professional Premium Access

Combined administration of atorvastatin and mesenchymal stem cells synergizes to attenuate inflammation and promote efferocytosis in atherosclerotic mice

Session: Atherosclerosis and inflammation

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Mr Q. Pan (Beijing, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Qi Pan

Beijing (China)

0 follower

6 more presentations in this session

Blockade of foam cell formation by an AP-1 inhibitor attenuates atherosclerosis in diabetes

Speaker: Doctor A. Khan (Melbourne, AU)

Monocyte response to mitochondrial DAMPs in elderly subjects: a possible contribution to chronic inflammation and atherosclerosis

Speaker: Professor A. Mattioli (Bologna, IT)

Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo

Speaker: Associate Professor C. Bursill (Adelaide, AU)

Macrophages overexpressing interleukin-10 target and prevent atherosclerosis: regression of plaque formation and reduction in necrotic core

Speaker: Doctor M. Wang (Beijing, CN)

C-C motif chemokine ligand 3 is associated with atherosclerotic plaque vulnerability and increased risk of mortality

Speaker: Doctor Y. Li (Malmo, SE)

Access the full session

Atherosclerosis and inflammation

Speakers: Mr Q. Pan, Doctor A. Khan, Professor A. Mattioli, Associate Professor C. Bursill, Doctor M. Wang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources